Annals of Oncology Advance Access published online on June 9, 2005
Annals of Oncology, doi:10.1093/annonc/mdi277
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Departments of Internal Medicine, Clínica Puerta de Hierro, Madrid, Spain
* To whom correspondence should be addressed. Background: Localized low-grade gastric mucosa-associated lymphoid tissue (MALT) lymphoma can regress after Helicobacter pylori eradication, but IgVH gene monoclonality may persist. We studied the long-term histological and molecular follow-up of 24 patients and the possible association of t(11;18) with the persistent monoclonality. Patients and methods: From January 1994, 24 untreated patients with stage I low-grade gastric MALT lymphoma associated with H. pylori were prospectively studied. They all received eradication treatment and were sequentially followed-up with endoscopies for histological and molecular studies. Rearrangement of the IgVH gene was studied by PCR analysis. MALT1 locus alterations were studied by FISH. Results: Twenty-two of the 24 patients (91%) achieved disappearance of the lymphoma. Eighteen (82%) of the 22 histologically cured patients and 16 of the 19 (84%) with long follow-up had monoclonality. Three patterns of development of IgVH gene rearrangements were observed: four patients (21%) had polyclonal rearrangements; eight (58%) had maintained/intermittent monoclonality and four (21%) had occasional monoclonality, mostly after H. pylori reinfection. Only one patient (6%) with persistent monoclonality relapsed. The remaining 18 patients maintained the remission, despite the persistent monoclonality in 15, for a median of 66 months (range 20-113). t(11;18) was not found in any of the patients with persistent monoclonality. Time and the number of endoscopies performed were not related with the occurrence of monoclonality. Conclusions: In stage I low-grade gastric MALT lymphoma eradication of H. pylori achieves prolonged histological remission in 90% of patients, but molecular remission is not accomplished in most cases. Molecular disease persists for years, but is not associated with t(11;18).
Received February 2, 2005
Revised April 28, 2005
Accepted April 29, 2005
Original article
Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study
2 , Departments ofPathology, Clínica Puerta de Hierro, Madrid, Spain
3 , Departments ofGastroenterology and , Clínica Puerta de Hierro, Madrid, Spain
4 , Departments ofBiostatistics Unit, Hospital Ramón y Cajal,, Madrid, Spain
5 Department of Pathology, Clínica Puerta de Hierro, Madrid, Spain
C. Montalban, E-mail: cmontalban.hrc{at}salud.madrid.org
Abstract 
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Stathis, C. Chini, F. Bertoni, I. Proserpio, C. Capella, L. Mazzucchelli, E. Pedrinis, F. Cavalli, G. Pinotti, and E. Zucca Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type Ann. Onc., June 1, 2009; 20(6): 1086 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W Fischbach, M E Goebeler, A Ruskone-Fourmestraux, T Wundisch, A Neubauer, M Raderer, A Savio, and for the EGILS (European Gastro-Intestinal Lymphoma Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series Gut, December 1, 2007; 56(12): 1685 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M Bacon, M.-Q. Du, and A. Dogan Mucosa-associated lymphoid tissue (MALT) lymphoma: a practical guide for pathologists J. Clin. Pathol., April 1, 2007; 60(4): 361 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Cohen, M. Petryk, M. Varma, P. S. Kozuch, E. D. Ames, and M. L. Grossbard Non-Hodgkin's Lymphoma of Mucosa-Associated Lymphoid Tissue Oncologist, November 1, 2006; 11(10): 1100 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Streubel, D. Huber, S. Wohrer, A. Chott, and M. Raderer Reverse Transcription-PCR for t(11;18)(q21;q21) Staging and Monitoring in Mucosa-Associated Lymphoid Tissue Lymphoma. Clin. Cancer Res., October 15, 2006; 12(20): 6023 - 6028. [Abstract] [Full Text] [PDF]
|
|